Glenn Treisman, MD, PhD, is the director of the AIDS Psychiatry Program and a professor of psychiatry and behavioral sciences and internal medicine at The Johns Hopkins University School of Medicine in Baltimore, Maryland. He has been involved in the care of HIV-infected patients with psychiatric illness since early in the epidemic, and has raised awareness of mental illness associated with HIV and the barrier it creates to effective care.
 

Dr. Treisman is also a lecturer at the Johns Hopkins School of Medicine in courses on neuroscience, psychiatry, pharmacology clinical skills, and the role of physicians in society, as well as a lecturer at the Bloomberg School of Public Health.
 

Dr. Treisman has been described as "the father of AIDS psychiatry" because of his groundbreaking work with HIV. He is known internationally for his presentations defending psychiatry and his vigorous commitment to patient care for underserved populations, such as HIV patients. Dr. Treisman is the author of The Psychiatry of AIDS as well as numerous articles on mental health issues associated with HIV.
 

In 2006, Dr. Treisman received the William C. Menninger Memorial Award for Distinguished Contribution to the Science of Mental Health from the American College of Physicians. He has received the Chairman's Award for Teaching from the Department of Medicine at Johns Hopkins School of Medicine. His lectures on psychiatry and medical ethics have earned him numerous international invitations, such as the Mapother Lecture in London, England, and Findling Lecture at Mayo Clinic.
 

Dr. Treisman earned his PhD in pharmacology and has a background in geriatric psychiatry. He has worked at the interface between medicine and psychiatry, and has become a noted clinical expert on depression, addiction, personality disorders, chronic pain, and the interaction between psychiatric disorders and medical illness.

Andrew Nierenberg, MD, graduated from the Albert Einstein College of Medicine of Yeshiva University, Bronx, New York. He did his residency in psychiatry at New York University/Bellevue Hospital in New York City, where he became a chief resident, and then went on as a Robert Wood Johnson Clinical Scholar at Yale University to study clinical epidemiology. He continued his trek north to join the faculty at Harvard, and then to direct the Affective Disorders Outpatient Unit at McLean Hospital.
 

Dr. Nierenberg then joined the Psychopharmacology Unit at Massachusetts General Hospital in Boston in 1992, where he is currently Associate Director of the Depression Clinical and Research Program, Medical Director of the Bipolar Programs, and Associate Professor of Psychiatry at Harvard Medical School. His primary interests are treatment resistant depression, management of antidepressant side effects, the longitudinal course of affective disorders, and pharmacoepidemiology.

Michael E. Thase, MD, has worked at the Western Psychiatric Institute and Clinic for more than 23 years. He recently joined the faculty of the University of Pennsylvania School of Medicine, where he is Professor of Psychiatry.  An active clinical investigator, Dr. Thase's research focuses on the assessment and treatment of mood disorders, including the correlates of differential response to various treatments for depression and bipolar affective disorder.

A 1979 graduate of the Ohio State University College of Medicine, Dr. Thase is a Distinguished Fellow of the American Psychiatric Association, a Founding Fellow of the Academy of Cognitive Therapy, and has been elected to the membership of the American College of Psychiatrists and the American College of Neuropsychopharmacology.

Dr. Thase has authored or co-authored nearly 500 scientific articles and book chapters, as well as 15 books.